SCOPUS 정보 검색 플랫폼

Neurology

Volumn 74, Issue 6, 2010, Pages 521-523

Severe cutaneous candida infection during natalizumab therapy in multiple sclerosis

(6) Gutwinski, S a Erbe, S a Munch C a Janke, O a Muller U a Haas, J a

a Jewish Hospital Berlin (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; CORTICOSTEROID DERIVATIVE; FLUCONAZOLE; GADOLINIUM; IMMUNOGLOBULIN G; NATALIZUMAB;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG TOLERABILITY; EXPANDED DISABILITY STATUS SCALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKIN CANDIDIASIS; TREATMENT RESPONSE;

EID: 76649088018 PISSN: 00283878 EISSN: 1526632X Source Type: Journal
DOI: 10.1212/WNL.0b013e3181cef810 Document Type: Article

Times cited : (22)

References (7)

1
- 17644398787
- Anti-alpha4 integrin therapy for multiple sclerosis: Mechanisms and rationale
- Rice GP, Hartung HP, Calabresi PA. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 2005;64:1336-1342.
- (2005) Neurology , vol.64 , pp. 1336-1342
- Rice, G.P.¹ Hartung, H.P.² Calabresi, P.A.³

2
- 0037413467
- A controlled trial of natalizumab for relapsing multiple sclerosis
- Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003;348:15-23.
- (2003) N Engl J Med , vol.348 , pp. 15-23
- Miller, D.H.¹ Khan, O.A.² Sheremata, W.A.³

3
- 54049087015
- Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- Goodin DS, Cohen BA, O'Connor P, Kappos L, Stevens JC. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;71:766-773.
- (2008) Neurology , vol.71 , pp. 766-773
- Goodin, D.S.¹ Cohen, B.A.² O'Connor, P.³ Kappos, L.⁴ Stevens, J.C.⁵

4
- 5644294299
- Prevalence and risk factors for superficial fungal infections among Italian Navy Cadets
- Ingordo V, Naldi L, Fracchiolla S, Colecchia B. Prevalence and risk factors for superficial fungal infections among Italian Navy Cadets. Dermatology 2004;209:190-196.
- (2004) Dermatology , vol.209 , pp. 190-196
- Ingordo, V.¹ Naldi, L.² Fracchiolla, S.³ Colecchia, B.⁴

5
- 70350501502
- Skin infections in 401 renal transplant recipients in southern Turkey
- Dicle O, Parmaksizoglu B, Gurkan A, Tuncer M, Demir-bas A, Yilmaz E. Skin infections in 401 renal transplant recipients in southern Turkey. Exp Clin Transplant 2009; 7:133-136.
- (2009) Exp Clin Transplant , vol.7 , pp. 133-136
- Dicle, O.¹ Parmaksizoglu, B.² Gurkan, A.³ Tuncer, M.⁴ Demir-Bas, A.⁵ Yilmaz, E.⁶

6
- 22844445230
- Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
- Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelle-tier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005;353: 375-381.
- (2005) N Engl J Med , vol.353 , pp. 375-381
- Langer-Gould, A.¹ Atlas, S.W.² Green, A.J.³ Bollen, A.W.⁴ Pelle-Tier, D.⁵

7
- 70149102687
- Reemergence of PML in natalizumab-treated patients: New cases, same concerns
- Major EO. Reemergence of PML in natalizumab-treated patients: new cases, same concerns. N Engl J Med 2009; 361:1041-1043.
- (2009) N Engl J Med , vol.361 , pp. 1041-1043
- Major, E.O.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.